Publications Database

Chez M. G. et al. (2002)

Double-blind, placebo-controlled study of L-carnosine supplementation in children with autistic spectrum disorders.

Journal of Child Neurology

17(11), pp. 833-837

Read Abstract (New Window)

Chez M. G. et al. (2000)

Secretin and autism: a two-part clinical investigation.

Journal of Autism and Developmental Disorders

30(2), pp. 87-94

Read Abstract (New Window)

Coniglio S. J. et al. (2001)

A randomized, double-blind, placebo-controlled trial of single-dose intravenous secretin as treatment for children with autism.

Journal of Pediatrics

138(5), pp. 649–655.

Coplan J. et al. (2003)

Children with autistic spectrum disorders. II: Parents are unable to distinguish secretin from placebo under double-blind conditions.

Archives of Disease in Childhood

88(9),

Read Full (New Window)

Corbett B. A. , Khan K. , Czapansky-Beilman D. (2001)

A double-blind, placebo-controlled crossover study investigating the effect of porcine secretin in children with autism.

Clinical Pediatrics

40(6),

Read Abstract (New Window)

Corbett B. A. , Ferrer E. , Shickman K. (2008)

Brief report: The effects of Tomatis sound therapy on language in children with autism

Journal of Autism and Developmental Disorders

March, 38(3), pp. 562-566

Read Abstract (New Window)

Curran M. (2011)

Aripiprazole: in the treatment of irritability associated with autistic disorder in pediatric patients.

Pediatric Drugs

13(3), pp. 197-204

Read Abstract (New Window)

Dadds M. R. et al. (2014)

Nasal oxytocin for social deficits in childhood autism: A randomized controlled trial.

Journal of Autism and Developmental Disorders

44(3), pp. 521-531.

Read Abstract (New Window)

Danfors T. et al. (2005)

Tetrahydrobiopterin in the treatment of children with autistic disorder: a double-blind placebo-controlled crossover study.

Journal of Clinical Psychopharmacology

25(5), pp. 485-489

Read Abstract (New Window)

Dolske M. et al. (1993)

A preliminary trial of ascorbic acid as supplemental therapy for autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

17 pp. 765-774

Read Abstract (New Window)

Edelson S. M. et al. (1999)

Auditory integration training: a double-blind study of behavioral and electrophysiological effects in people with autism.

Focus on Autism and Other Developmental Disabilities

14 pp. 73-81.

Read Abstract (New Window)

Enticott P. G. et al. (2014)

A double-blind, randomized trial of deep repetitive transcranial magnetic stimulation (rTMS) for autism spectrum disorder.

Brain Stimulation

March, 7(2), pp. 206-211.

Read Abstract (New Window)

Fahmy S. F. et al. (2013)

L-carnitine supplementation improves the behavioral symptoms in autistic children.

Research in Autism Spectrum Disorders

7(1), pp. 159-166.

Read Abstract (New Window)

Fankhauser M. et al. (1992)

A double-blind, placebo-controlled study of the efficacy of transdermal clonidine in autism.

Journal of Clinical Psychiatry

53(3), pp. 77-82

Read Abstract (New Window)

Feldman H. M. , Kolmen B. K. , Gonzaga A. M. (1999)

Naltrexone and communication skills in young children with autism.

Journal of the American Academy of Child and Adolescent Psychiatry

38(5), pp. 587-593

Read Abstract (New Window)

Findling R. L. et al. (2014)

A randomized controlled trial investigating the safety and efficacy of aripiprazole in the long-term maintenance treatment of pediatric patients with irritability associated with autistic disorder.

Journal of Clinical Psychiatry

75(1), pp. 22-30,

Read Abstract (New Window)

Findling R. L. et al. (1997)

High-dose pyridoxine and magnesium administration in children with autistic disorder: An absence of salutary effects in a double-blind, placebo-controlled study.

Journal of Autism and Developmental Disorders

27(4), pp. 467-478

Read Abstract (New Window)

Frye R. E. et al.

Folinic acid improves verbal communication in children with autism and language impairment: a randomized double-blind placebo-controlled trial.

Molecular Psychiatry

Read Full (New Window)

Garstang J. , Wallis M. (2006)

Randomized controlled trial of melatonin for children with autistic spectrum disorders and sleep problems.

Child: Care, Health and Development

32(5), pp. 585-589

Read Abstract (New Window)

Geier D. A. et al. (2011)

A prospective double-blind, randomized clinical trial of levocarnitine to treat autism spectrum disorders.

Medical Science Monitor

17(6), pp. 15-123

Read Abstract (New Window)